FTC, Impax Spar At 5th Circ. Over Opana ER Deal
Impax Laboratories defended its settlement agreement with Endo Pharmaceuticals over opioid pain medication Opana ER during oral argument at the Fifth Circuit on Tuesday, as the Federal Trade Commission insisted the...To view the full article, register now.
Already a subscriber? Click here to view full article